Moloney murine leukemia virus retropepsin

Handbook of Proteolytic Enzymes, Second Edition: Volume 1: Aspartic and Metallo Peptidases

Volumn 1, Issue , 2004, Pages 176-178

  Menéndez Arias, Luis ^a   Tözsér, József ^b   Oroszlan, Stephen ^c  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF DEBRECEN   (Hungary)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 16544374017     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-12-079611-3.50058-6     Document Type: Chapter

References (24)

1. L.J. Arcement, W.L. Karshin, R.B. Naso, G. Jamjoom and R.B. Arlinghaus (1976) Biosynthesis of Rauscher leukemia viral proteins: presence of p30 and envelope pl5 sequences in precursor polyproteins. Virology 69 763-774.
2. M. Barbacid, J.R. Stephenson and S.A. Aaronson (1976) gag Gene of mammalian type-C RNA tumour viruses. Nature 262 554-559.
3. P.L. Black, M.B. Downs, M.G. Lewis, M.A. Ussery, G.B. Dreyer, S.R. Petteway Jr. and D.M. Lambert (1993) Antiretroviral activities of protease inhibitors against murine leukemia virus and simian immunodeficiency virus in tissue culture. Antimicrob. Agents Chemother. 37 71-77.
4. P. Boross, P. Bagossi, T.D. Copeland, S. Oroszlan, J.M. Louis and J. Tözsér (1999) Effect of substrate residues on the P2′ preference of retroviral proteinases. Eur. J. Biochem. 264 921-929.
5. P. Calkins and R.B. Luftig (1989) Bacterial expression and activity of the Moloney murine leukemia virus proteinase. H.-G. Kräusslich, S. Oroszlan,E. Wimmer (Eds) Viral Proteinases as Targets for Chemotherapy Cold Spring Harbor: Cold Spring Harbor Laboratory Press 113-116.
6. K. Cannon, L. Qin, G. Schumann and J.D. Boeke (1998) Moloney murine leukemia virus protease expressed in bacteria is enzymatically active. Arch. Virol. 143 381-388.
7. S. Crawford and S.P. Goff (1985) A deletion mutation in the 5′ part of the pol gene of Moloney murine leukemia virus blocks proteolytic processing of the gag pol polyproteins. J. Virol. 53 899-907.
8. L.E. Henderson, R. Sowder, T.D. Copeland, G. Smythers and S. Oroszlan (1984) Quantitative separation of murine leukemia virus proteins by reversed-phase high-pressure liquid chromatography reveals newly described gag env cleavage products. J. Virol. 52 492-500.
9. G.A. Jamjoom, R.B. Naso and R.B. Arlinghaus (1977) Further characterization of intracellular precursor polyproteins of Rauscher leukemia virus. Virology 78 11-34.
10. I. Katoh, Y. Yoshinaka, A. Rein, M. Shibuya, T. Odaka and S. Oroszlan (1985) Murine leukemia virus maturation: protease region required for conversion from ‘immature’ to ‘mature’ core form and for virus infectivity. Virology 145 280-292.
11. M.-H.T. Lai, J. Tang, V. Wroblewski, A.G. Dee, N. Margolin, C. Vlahos, B. Bowdon, R. Buckheit, J. Colacino and K.Y. Hui (1993) Impeded progression of Friend disease in mice by an inhibitor of retroviral proteases. J. Acquir. Immune Defic. Syndr. 6 24-31.
12. L. Menéndez-Arias, D. Gotte and S. Oroszlan (1993) Moloney murine leukemia virus protease: bacterial expression and characterization of the purified enzyme. Virology 196 557-563.
13. L. Menéndez-Arias, I.T. Weber, J. Soss, R.W. Harrison, D. Gotte and S. Oroszlan (1994) Kinetic and modeling studies of subsites S4–S3′ of Moloney murine leukemia virus protease. J. Biol. Chem. 269 16795-16801.
14. L. Menéndez-Arias, I.T. Weber and S. Oroszlan (1995) Mutational analysis of the substrate binding pocket of murine leukemia virus protease and comparison with human immunodeficiency virus proteases. J. Biol. Chem. 270 29162-29168.
15. S. Oroszlan and R.B. Luftig (1990) Retroviral proteinases. Curr. Top. Microbiol. Immunol. 157 153-185.
16. S. Oroszlan, L.E. Henderson, J.R. Stephenson, T.D. Copeland, C.W. Long, J.N. Ihle and R.V. Gilden (1978) Amino- and carboxyl-terminal amino acid sequences of proteins coded by gag gene of murine leukemia virus. Proc. Natl Acad. Sci. USA 75 1404-1408.
17. A. Rein, J. Mirro, J.G. Haynes, S.M. Ernst and K. Nagashima (1994) Function of the cytoplasmic domain of a retroviral transmembrane protein: p15E-p2E cleavage activates the membrane fusion capability of the murine leukemia virus Env protein. J. Virol. 68 1773-1781.
18. A. Schultz and A. Rein (1985) Maturation of murine leukemia virus env proteins in the absence of other viral proteins. Virology 145 335-339.
19. Y. Yoshinaka and R.B. Luftig (1977) Murine leukemia virus morphogenesis: cleavage of P70 in vitro can be accompanied by a shift from a concentrically coiled internal strand (‘immature’) to a collapsed (‘mature’) form of the virus core. Proc. Natl Acad. Sci. USA 74 3446-3450.
20. Y. Yoshinaka and R.B. Luftig (1977) Properties of a P70 proteolytic factor of murine leukemia viruses. Cell 12 709-720.
21. Y. Yoshinaka and R.B. Luftig (1978) Morphological conversion of ‘immature’ Rauscher leukaemia virus cores to a ‘mature’ form after addition of the P65–70 (gag gene product) proteolytic factor. J. Gen. Virol. 40 151-160.
22. Y. Yoshinaka and R.B. Luftig (1980) Physicochemical characterization and specificity of the murine leukaemia virus Pr65gagproteolytic factor. J. Gen. Virol. 48 329-340.
23. Y. Yoshinaka, I. Katoh, T.D. Copeland and S. Oroszlan (1985) Murine leukemia virus protease is encoded by the gag-pol gene and is synthesized through suppression of an amber termination codon. Proc. Natl Acad. Sci. USA 82 1618-1622.
24. Y. Yoshinaka, I. Katoh, T.D. Copeland and S. Oroszlan (1985) Translational readthrough of an amber termination codon during synthesis of feline leukemia virus protease. J. Virol. 55 870-873.